Comparison of the Efficacy of Peloid Therapy and Paraffin Treatment in Carpal Tunnel Syndrome - Trial NCT06405438
Access comprehensive clinical trial information for NCT06405438 through Pure Global AI's free database. This phase not specified trial is sponsored by Beylikduzu State Hospital and is currently Not yet recruiting. The study focuses on Carpal Tunnel Syndrome. Target enrollment is 60 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Beylikduzu State Hospital
Timeline & Enrollment
N/A
Jun 01, 2024
Oct 01, 2024
Primary Outcome
Boston Carpal Tunnel Syndrome Questionnaire
Summary
This study compares the effectiveness of peloid therapy and paraffin treatment in carpal
 tunnel syndrome. Patients receive either 2 weeks of peloid therapy or 15 sessions of paraffin
 treatment, along with splint therapy for 3 months. Pain and symptom severity are assessed
 using the Visual Analog Scale (VAS) and Boston Carpal Tunnel Syndrome Questionnaire (BCTQ).
 Results are measured at baseline, 4 weeks post-treatment, and a 12-week follow-up.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06405438
Non-Device Trial